US4523271090 - Common Stock
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Top S&P500 movers in Monday's session
Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
There's reason to believe that the future is starting to look better.
Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.
Activist investor Icahn's blessing is a relief for the company as it tries to rebound from a bitter proxy fight with the billionaire investor.
Illumina investor Carl Icahn said Wednesday via X that the company’s incoming CEO, Jacob Thaysen, has his “full support.” Read more here.
The European Commission has appointed Belgium's Didier Reynders as the EU's competition chief, while incumbent commissioner Margrethe Vestager takes a leave of absence to run for the top job at the European Investment Bank. - Illumina has appointed Jacob Thaysen as its new chief executive, as the biotech group seeks to rebuild its leadership team following a bruising battle with activist investor Carl Icahn.
The announcement comes after a proxy fight with activist investor Carl Icahn, which ended with Illumina's former CEO Francis deSouza voluntarily stepping down.
Illumina (ILMN) said Tuesday that Jacob Thaysen, president of Agilent Technologies' (A) Life Sciences and Applied Markets Group, will be its next CEO. Read more here.
Illumina Inc. on Tuesday announced that its board has appointed Agilent Technologies Inc. senior vice president Jacob Thaysen as its new CEO, effective Sept....
U.S. genetic testing company Illumina Inc said on Tuesday its board had named Agilent Technologies' executive Jacob Thaysen as the company's CEO.
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has...
Read why Evercore ISI added Illumina, Inc. (ILMN) to the broker's Tactical Outperform list. Read more here.
Illumina Inc. shares may be poised for a turnaround as the company hunts for a new CEO, Evercore ISI analysts wrote in a research note Friday. The analysts...
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: Morgan Stanley 21st...